Skip to main content
Equibles
SUPN logo

SUPN · Supernus Pharmaceuticals, Inc. · Analyst Estimates

Track SUPN — free

Use SUPN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SUPN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$41.69 -0.38 (-0.90%) At close · Sep 10
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.45B
Shares
58.13M

Analyst Estimates

Compare analyst forecasts for Supernus Pharmaceuticals, Inc. across metrics and forecast periods.

Low, average and high estimates appear together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1356576 CUSIP 868459108 13F (30d) 177 filings 176 filers Visit website Investor relations